Funded Startups in Esch-sur-alzette
Among the 6 most recent funded startups shown for Esch-sur-alzette, the largest disclosed round is Passbolt’s $8M Series A on 2025-01-23; it sits above the…
Among the 6 most recent funded startups shown for Esch-sur-alzette, the largest disclosed round is Passbolt’s $8M Series A on 2025-01-23; it sits above the rest of the disclosed amounts, which cluster at $2M (Exobiosphere $2M on 2025-04-04; Scorechain $2M on 2021-10-20) and $1M (Yotako $1M on 2021-06-02). Disclosed values also show an outlier pattern in the other direction: three of the six entries list “undisclosed” amounts (NIUM 2024-09-11; Anisoprint 2023-10-25).
The list concentrates in a relatively tight temporal window at the top: two rounds with disclosed amounts occurred between January and April 2025 (Passbolt 2025-01-23; Exobiosphere 2025-04-04). Sector-wise, Biotechnology appears in 2 of 6 entries (Exobiosphere and NIUM), while the remaining sectors are split across Information Technology, Manufacturing, Financial Services, and Apps. Stages are mixed: one entry is “Series Unknown” (Anisoprint 2023-10-25) and one entry has a blank stage (Yotako 2021-06-02), spanning round dates from 2021-06-02 through the most recent 2025-04-04.
Most recent rounds
6 shownRelated listings
Frequently asked
What’s the largest disclosed round in Esch-sur-alzette here, and how does it compare to other disclosed amounts?
Passbolt’s $8M (Series A) on 2025-01-23 is the only disclosed amount above the $2M–$1M range. The other disclosed rounds are $2M for Exobiosphere (2025-04-04) and Scorechain (2021-10-20), plus $1M for Yotako (2021-06-02).
Are the most recent closings clustered in time, or spread out?
They cluster at the recent end: two disclosed rounds fall within 2025-01-23 to 2025-04-04 (Passbolt $8M on 2025-01-23; Exobiosphere $2M on 2025-04-04). Beyond that, the next disclosed amounts shown appear years earlier (Scorechain $2M on 2021-10-20; Yotako $1M on 2021-06-02), with multiple “undisclosed” entries between 2023 and 2024.
Which stage labels dominate, and how much is missing or unspecified?
Only one entry is explicitly labeled “Series A” (Passbolt $8M on 2025-01-23), while one is explicitly “Series Unknown” (Anisoprint on 2023-10-25) and one has a blank stage (Yotako on 2021-06-02). In parallel, three of six entries mark the amount as “undisclosed” (NIUM 2024-09-11; Anisoprint 2023-10-25; NIUM/Anisoprint aside, only Exobiosphere, Passbolt, Scorechain, and Yotako show disclosed amounts).
Is any sector over-represented in this Esch-sur-alzette list?
Biotechnology is the only sector repeated in 2 of 6 entries (Exobiosphere in Biotechnology on 2025-04-04 and NIUM in Biotechnology on 2024-09-11). The other sectors appear once each: Information Technology (Passbolt), Manufacturing (Anisoprint), Financial Services (Scorechain), and Apps (Yotako).
Are there outliers worth focusing on beyond the $8M Passbolt round?
Yes: disclosure itself is an outlier pattern, with half the list showing “undisclosed” amounts (NIUM on 2024-09-11; Anisoprint on 2023-10-25), while the disclosed values are confined to $1M–$8M. Sector-wise, the only non-Biotech outlier with a disclosed amount is still in the mid-range, with Scorechain at $2M (Financial Services on 2021-10-20) and Yotako at $1M (Apps on 2021-06-02).
What does the timeline look like across the 6 rows, from oldest to most recent?
Round dates span from 2021-06-02 (Yotako $1M) through 2025-04-04 (Exobiosphere $2M). The most recent entry is Exobiosphere on 2025-04-04, and the next-most-recent disclosed round is Passbolt on 2025-01-23, with two additional entries between 2023-10-25 and 2024-09-11 that both list “undisclosed” amounts.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.